Recent patents on nanosystems applications to anticancer drug therapy: Lipid-based systems

Abstract

The advent of nanomedicines allows a diversity of drugs with unfavorable biopharmaceutical properties and safety issues to be accessible as pharmaceutical products. The expectations are particularly high in the field of cancer therapeutics, where nanotechnology promises to enhance treatment selectivity, solving or ameliorating off-target toxicity issues. The biocompatible nature of lipid-based nanosystems and their scalable production make them especially auspicious for therapeutic applications. Here, we present an update on recent patents on lipid-based nanosystems (liposomes, solid lipid nanoparticles and nano-structured lipid carriers) applications to cancer therapy.